# Somatus

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/somatus

- Industry: Healthcare
- Headquarters: McLean, US
- Website: www.somatus.com
- Total disclosed funding: $405M
- Latest round: Series E (Feb 22, 2022)
- Investors on record: 12

## About

Founded in 2016 and based in Virginia, US, Somatus, Inc. operates as a value-based healthcare company specializing in kidney and cardiovascular care, partnering with health plans and providers to deliver integrated, AI-driven services that improve patient outcomes and reduce costs. The founder and CEO, Ikenna Okezie, has a background in healthcare innovation. Somatus, Inc. has raised a total of USD 465.12 million across 5 rounds of funding. In February 2022, Somatus, Inc. raised USD 325 million in series E funding led by new investor Wellington Management, with participation from other new investors Fidelity Investments, GIC, and RA Capital. Returning investors Anthem, Inc., BlueCross BlueShield Venture Partners, Deerfield Management, Flare Capital Partners, Inova Health System, Longitude Capital, Optum Ventures, and other unspecified investors also participated in the round. The series E round of funding values Somatus, Inc. at USD 2.59 billion. Somatus specializes in providing comprehensive care solutions for individuals with kidney and heart health concerns. The company offers individualized clinical, emotional, and social support tailored to each patient's unique needs, employing local health support teams to serve diverse populations across the US. Their focus is on improving patient experiences through personalized coaching and advocacy, facilitating better access to necessary resources and care. The company generates revenue through strategic partnerships with healthcare providers, insurers, and health plans, engaging in B2B transactions to offer its services to members of health plans. This model emphasizes improved patient outcomes and efficient resource utilization within the healthcare system, though specific pricing plans are not disclosed.

## Funding rounds

- Series E, Feb 22, 2022, $325M — GIC, Wellington Management, Longitude Capital, Fidelity Investments, INOVA Health System, BlueCross BlueShield Venture Partners, Deerfield Management, RA Capital Management, Elevance Health, Inc., Optum Ventures, Flare Capital Partners
- Series C, May 27, 2020, $64M — Longitude Capital, BlueCross BlueShield Venture Partners, Deerfield Management, Optum Ventures, Flare Capital Partners, Town Hall Ventures
- Series B, Mar 20, 2018, $11M — INOVA Health System, BlueCross BlueShield Venture Partners, Flare Capital Partners, Town Hall Ventures
- Series A, Apr 20, 2017, $5M — BlueCross BlueShield Venture Partners

## Investors

- BlueCross BlueShield Venture Partners (https://capitalatlas.ai/funds/bluecross-blueshield-venture-partners) — Series A, Series B, Series C, Series E
- INOVA Health System — Series B, Series E
- Flare Capital Partners (https://capitalatlas.ai/funds/flare-capital-partners) — Series B, Series C, Series E
- Town Hall Ventures (https://capitalatlas.ai/funds/town-hall-ventures) — Series B, Series C
- Longitude Capital (https://capitalatlas.ai/funds/longitude-capital) — Series C, Series E
- Deerfield Management (https://capitalatlas.ai/funds/deerfield-management) — Series C, Series E
- Optum Ventures (https://capitalatlas.ai/funds/optum-ventures) — Series C, Series E
- GIC — Series E
- Wellington Management (https://capitalatlas.ai/funds/wellington-management) — Series E
- Fidelity Investments (https://capitalatlas.ai/funds/fidelity-investments) — Series E
- RA Capital Management (https://capitalatlas.ai/funds/ra-capital-management) — Series E
- Elevance Health, Inc. — Series E